SMX Security Matters plc vs 10X Genomics Inc — how do they compare? SMX Security Matters plc trades at $3.79 (market cap $4.13M), while 10X Genomics Inc trades at $84.49 (market cap $10.07B). The key difference: 10X Genomics Inc is far larger — about 2438.3× SMX Security Matters plc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SMX Security Matters plc for 21 Days and 10X Genomics Inc for 92 Days on average.
| SMX | TXG | |
|---|---|---|
Market Cap | $4.13M | $10.07B |
Volume | 124,362 | 5,657,286 |
Sector | Industrials | Health |
52-Week High | $74.08K | $97.74 |
52-Week Low | $3.79 | $11.48 |
Typical Hold Time | 21 Days | 92 Days |
Enterprise Value | -$27.20M | $9.59B |
Signals from Pluang's Aura AI — not financial advice
SMX trades at $3.90, up 2.9% today, but faces significant financial challenges with no revenue reported for 2025 and a net loss of $169.18 million. The stock shows bearish technical signals with moving averages indicating selling pressure, though oscillators suggest potential short-term momentum. Recent news highlights the company's focus on recycled plastic verification technology and growing media coverage from major outlets.
The outlook remains highly speculative given the absence of revenue and substantial losses. Investment opportunity hinges on successful commercialization of SMX's material verification platform, while risks include cash burn sustainability and intense competition in the circular economy space. Wall Street sentiment appears cautious due to the company's unproven business model.
TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.
The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →